Patrik Dahlén new CEO of DakoCytomation A/S
The Board of Directors of DakoCytomation A/S has resolved to appoint Patrik Dahlén CEO of DakoCytomation. Patrik Dahlén has been acting CEO since August 1, 2005.
"During the past few months we have searched the global market for potential candidates through one of the world's leading recruitment companies. We have now completed this search and found that Patrik Dahlén is the best match for the position. Over just a short period of time, Patrik Dahlén has demonstrated great management skills and drive, which we are sure will strengthen DakoCytomation's performance and growth in the years to come," said Sonnich Fryland, Chairman of the Board of Directors of DakoCytomation.
Patrik Dahlén will remain a member of the Board of Directors of DakoCytomation until the next annual general meeting.
Patrik Dahlén's career includes positions with PerkinElmer Inc., where he was president of the Life Sciences business unit, and EG&G Wallac OY, where he was head of the Diagnostics Systems Division.
Other news from the department people
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.